Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Agilis Radiofrequency Transseptal System Early Feasibility Study

NCT07361445 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT07361445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07361445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Agilis Radiofrequency Transseptal System Early Feasibility Study
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Recruiting
Start date
February 16, 2026
Completion date
August 3, 2026
Enrollment
60 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac arrythmias, left atrial appendage closure